发明授权
US07611904B2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
有权
在人类癌症中表达的蛇纹石跨膜抗原及其用途
- 专利标题: Serpentine transmembrane antigens expressed in human cancers and uses thereof
- 专利标题(中): 在人类癌症中表达的蛇纹石跨膜抗原及其用途
-
申请号: US11580538申请日: 2006-10-12
-
公开(公告)号: US07611904B2公开(公告)日: 2009-11-03
- 发明人: Daniel E. Afar , Rene S. Hubert , Kahan Leong , Arthur B. Raitano , Douglas C. Saffran , Stephen Chappell Mitchell
- 申请人: Daniel E. Afar , Rene S. Hubert , Kahan Leong , Arthur B. Raitano , Douglas C. Saffran , Stephen Chappell Mitchell
- 申请人地址: US CA Santa Monica
- 专利权人: Agensys, Inc.
- 当前专利权人: Agensys, Inc.
- 当前专利权人地址: US CA Santa Monica
- 代理商 Atulya Agarwal; Shane M. Popp, J.D., L.L.M.; Ginger R. Dreger
- 主分类号: G01N33/53
- IPC分类号: G01N33/53
摘要:
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed “STEAP” (SIX Transmembrane Epithelial Antigens of the Prostate). Four particular human STEAPs are described and characterized herein. The human STEAPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STEAP family, STEAP-1, appears to be a type IIIa membrane protein expressed predominantly in prostate cells in normal human tissues. Structurally, STEAP-1 is a 339 amino acid protein characterized by a molecular topology of six transmembrane domains and intracellular N- and C-termini, suggesting that it folds in a “serpentine” manner into three extracellular and two intracellular loops. STEAP-1 protein expression is maintained at high levels across various stages of prostate cancer. Moreover, STEAP-1 is highly over-expressed in certain other human cancers.
公开/授权文献
信息查询
IPC分类: